Financhill
Back

Aptevo Therapeutics Quote, Financials, Valuation and Earnings

Aptevo Therapeutics Price Quote

$4.10
+0.01 (+-27.18%)
(Updated: December 14, 2024 at 5:23 AM ET)

Aptevo Therapeutics Key Stats

Sell
14
Aptevo Therapeutics (APVO) is a Sell

Day range:
$4.08 - $5.95
52-week range:
$4.08 - $399.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.03
P/B ratio:
0.46%

Volume:
805.6K
Avg. volume:
320.4K
1-year change:
-98.56%
Market cap:
$2M
Revenue:
$0
EPS:
$-3598.31

How Much Does Aptevo Therapeutics Make?

Data Unavailable

Is Aptevo Therapeutics Growing As A Company?

Data Unavailable

Aptevo Therapeutics Stock Price Performance

What Is Aptevo Therapeutics 52-Week High & Low?

Aptevo Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aptevo Therapeutics?

Is Aptevo Therapeutics Cash Flow Positive?

  • What Is APVO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$23.3M
  • What Is Aptevo Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $11.9M
  • What Is Aptevo Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Aptevo Therapeutics Return On Invested Capital

Data Unavailable

Aptevo Therapeutics Earnings Date & Stock Price

Aptevo Therapeutics Competitors

Aptevo Therapeutics Dividend Yield

Aptevo Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 15.79%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 296.00
Upside from Last Price: 7137.17%

Major Shareholders

  • How many APVO shares are owned by institutional investors?
    1.8M APVO shares are owned by institutional investors
  • How many APVO shares are owned by insiders?
    0 APVO shares are owned by insiders